Mirion Technologies (MIR) Goldman Sachs Industrials and Materials Conference summary
Event summary combining transcript, slides, and related documents.
Goldman Sachs Industrials and Materials Conference summary
11 Jan, 2026Business overview and market positioning
Operates as a pure play in ionizing radiation detection, measurement, and analysis, leading 17 of 19 global product categories.
Holds a unique technological leverage, enabling discoveries to be applied across multiple verticals and segments.
Two-thirds of revenue comes from nuclear and safety, with the remainder from medical applications.
Maintains a presence in over 95% of the world’s operating nuclear reactors, participating throughout the plant lifecycle.
Recurring revenue from the installed base forms 80% of nuclear segment revenue, providing predictability and defensibility.
Nuclear segment dynamics and growth drivers
Nuclear power is the largest sub-segment, with significant exposure to the global nuclear renaissance and energy transition.
Industry tailwinds include decarbonization, energy security, and increased demand from the AI revolution and electric economy.
Operators are shifting to expansionary modes, driving higher capacity factors, asset life extensions, and faster replacement cycles.
Robust new build pipeline, especially in Europe, North Africa, the Gulf, Korea, and India, with strategic partnerships like ECIL and EDF.
SMR (small modular reactor) market is emerging, with higher revenue per megawatt than utility scale, and tangible early backlog.
Financial targets and operational strategy
Long-term organic growth guidance of 6%-8%, with nuclear and nuclear medicine expected to grow at high single digits.
Targeting 30% EBITDA margin, driven by operating leverage, procurement savings, and business system improvements.
Free cash flow expected to rise from $60M-$70M in 2024 to ~$200M by 2028, with linear margin progression.
2025 guidance includes 5.5%-7.5% organic growth and 4%-6% total revenue growth, with margin expansion not back-end loaded.
Focus on cost discipline, site closures, exiting unprofitable lines, and optimizing tax and interest expenses.
Latest events from Mirion Technologies
- Q3 2025 saw strong revenue, profit, and cash flow growth, with major nuclear wins and financings.MIR
Q3 202517 Mar 2026 - Nuclear and AI tailwinds fuel growth, margin expansion, and global market leadership.MIR
Citi's Global Industrial Tech & Mobility Conference 202618 Feb 2026 - Record orders and margin expansion in 2025 set the stage for strong 2026 growth.MIR
Q4 202511 Feb 2026 - Guidance raised to 6–8% organic growth and ~30% EBITDA margin by 2028, led by nuclear and medical momentum.MIR
Investor Day 20243 Feb 2026 - Q2 revenue up 5%, adjusted EBITDA up 10.2%, and guidance raised on strong segment growth.MIR
Q2 20242 Feb 2026 - Q1 2024 organic revenue up 5.5% as innovation and ESG drive growth in key markets.MIR
Jefferies Global Healthcare Conference1 Feb 2026 - Q3 revenue up 8.2%, margin expands, and 2024 guidance raised with improved leverage.MIR
Q3 202417 Jan 2026 - Record 2024 results, margin expansion, and strong 2025 outlook driven by nuclear and medical growth.MIR
Q4 202429 Dec 2025 - Q1 2025 delivered revenue, margin, and order growth, with guidance raised despite tariff headwinds.MIR
Q1 202524 Dec 2025